Epidemiology of high-level parvovirus B19 viraemia among Dutch blood donors, 2003-2009

Vox Sanguinis

Volumn 100, Issue 3, 2011, Pages 261-266

  Kooistra, K ^a   Mesman, H J ^a   de Waal, M ^a   Koppelman, M H G M ^a   Zaaijer, H L ^a,b  

^a CENTRAL LABORATORY   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Human parvovirus B19; NAT testing; Transfusion transmitted infections

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS DNA;

ADULT; AGED; ARTICLE; BLOOD DONOR; FEMALE; HUMAN; HUMAN PARVOVIRUS B19; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NONHUMAN; PARVOVIRUS INFECTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BLOOD DONORS; BLOOD TRANSFUSION; DNA, VIRAL; EPIDEMICS; HUMANS; MIDDLE AGED; NETHERLANDS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; VIREMIA; YOUNG ADULT;

EID: 79952517653     PISSN: 00429007     EISSN: 14230410     Source Type: Journal    
DOI: 10.1111/j.1423-0410.2010.01423.x     Document Type: Article

References (14)

1. Cossart YE, Field AM, Cant B, et al. Parvovirus-like particles in human sera. Lancet 1975; 1(7898):72-73
2. Parsyan A, Candotti D: Human erythrovirus B19 and blood transfusion - an update. Transfus Med 2007; 17:263-278
3. Brown KE, Anderson SM, Young NS: Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993; 262:114-117
4. Young NS, Brown KE: Parvovirus B19. N Engl J Med 2004; 350:586-597
5. Yu MW, Alter HJ, Virata-Theimer ML, et al. Parvovirus B19 infection transmitted by transfusion of red blood cells confirmed by molecular analysis of linked donor and recipient samples. Transfusion 2010; 50:1712-1721
6. Kleinman SH, Glynn SA, Lee TH, et al. A linked donor-recipient study to evaluate parvovirus B19 transmission by blood component transfusion. Blood 2009; 114:3677-3683
7. Koppelman MH, Rood IG, Fryer JF, et al. Parvovirus B19 genotypes 1 and 2 detection with real-time polymerase chain reaction assays. Vox Sang 2007; 93:208-215
8. Koppelman MH, Cuypers HT, Emrich T, et al. Quantitative real-time detection of parvovirus B19 DNA in plasma. Transfusion 2004; 44:97-103
9. RIVM. National Institute of Public Health and the Environment, The Netherlands. Infectieziektenbulletin: Accessed 3 May 2010
10. Schmidt M, Themann A, Drexler C, et al. Blood donor screening for parvovirus B19 in Germany and Austria. Transfusion 2007; 47:1775-1782
11. RIVM. National Institute for Public Health and the Environment, The Netherlands: Fifth disease every four years: parvovirus B19. Available at: Accessed 3 May 2010
12. Kelly HA, Siebert D, Hammond R, et al. The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world. Epidemiol Infect 2000; 124:449-457
13. Zaaijer HL, Koppelman MH, Farrington CP: Parvovirus B19 viraemia in Dutch blood donors. Epidemiol Infect 2004; 132:1161-1166
14. Mauser-Bunschoten EP, Zaaijer HL, van Drimmelen AA, et al. High prevalence of parvovirus B19 IgG antibodies among Dutch hemophilia patients. Vox Sang 1998; 74:225-227